FORM 8-K

Company

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Filed

June 26, 2025

Period of Report

June 26, 2025

Accession Number

0001437749-25-021361

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →